A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt trauma patients who require head CT imaging, and could significantly reduce the use of CT imaging. The findings of the study are published in the July issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine (SAEM).

A novel new study provides compelling evidence that the design, development and implementation of electronic health records (EHRs) need to be improved to make them easier to use by clinicians and, ultimately, safer for patients.

A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has developed an advanced computing technique for rapidly and cost effectively improving the quality of biomedical imaging. The technology, called AUTOMAP, uses machine learning and software, referred to as neural networks — inspired by the brain’s ability to process information and perceive or make choices. AUTOMAP finds the best computational strategies to produce clear, accurate images for various types of medical scans.

A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.

Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all prostate cancer radiotherapy patients in Japan through the Ministry of Health, Labour & Welfare (MHLW) national reimbursement. SpaceOAR hydrogel is clinically proven to assist in the decrease of unwanted side effects from radiotherapy treatment in patients with prostate cancer.

A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history. The blood test captures risk for people who have ever smoked, not only for heavy smokers, an international research team reports in JAMA Oncology.

At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia, Siemens Healthineers announced U.S. Food and Drug Administration (FDA) clearance of syngo.via VB30 for Molecular Imaging (MI). The latest version of the company’s intelligent imaging software, syngo.via VB30 for MI has new features designed to bring advanced clinical capabilities to positron emission tomography/computed tomography (PET/CT) imaging in oncology and neurology.

RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources.

July 13, 2018 — Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UC San Francisco.

iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular imaging analysis platform in Australia and New Zealand. Hospitals and clinics that treat ischemic stroke in these countries will now have access to RAPID’s automated computed tomography perfusion (CTP), magnetic resonance (MR), CT angiography (CTA) and ASPECTS solutions, with support from DIA’s customer service specialists in the region.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now